A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan With Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem-Cell Transplantation in the Modern Era: A Cohort Analysis

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.03.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Choosing a Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine Busulfan Versus Fludarabine Melphalan: A Systematic Review and Meta-Analysis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Comparison of Total Body Irradiation vs Busulfan in Combination With Cyclophosphamide as Conditioning for Unrelated Stem Cell Transplantation in CML Patients

Bone Marrow Transplantation
TransplantationHematology
2001English

Busulfan Fludarabine vs Busulfan Cyclophosphamide as a Preparative Regimen Before Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis

Bone Marrow Transplantation
TransplantationHematology
2015English

Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia With Cyclophosphamide in Combination With Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Fludarabine and Busulfan Versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Thiotepa/Cyclophosphamide/Tbi as a Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome

Bone Marrow Transplantation
TransplantationHematology
2004English

Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine as a Preparative Regimen for Allogeneic Haemopoietic Stem-Cell Transplantation in Patients With Acute Myeloid Leukaemia: An Open-Label, Multicentre, Randomised, Phase 3 Trial

The Lancet Oncology
Oncology
2015English

Thiotepa, Busulfan and Fludarabine Compared to Busulfan and Cyclophosphamide as Conditioning Regimen for Allogeneic Stem Cell Transplant From Matched Siblings and Unrelated Donors for Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy